Bridge to Life has received FDA De Novo clearance for its VitaSmart hypothermic oxygenated perfusion (HOPE) system for liver ...

Please provide your email address to receive an email when new articles are posted on . Circulatory death livers preserved for donation with normothermic machine perfusion had the lowest early ...

The FDA clearance enables the commercial use of VitaSmart (TM) for hypothermic oxygenated perfusion of donor livers following static cold storage and prior to transplantation, providing a clear, ...

Researching are throwing lots of ideas at the wall to see what sticks, but the U.S. just put some serious cash behind the ...

Normothermic machine perfusion (NMP) to preserve livers prior to transplant was associated with significantly improved clinical outcomes and reduced use of hospital resources compared with static cold ...

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment of primary and metastatic liver ...

CHICAGO, Sept. 18, 2025 /PRNewswire/ -- The first-ever multicenter study of Hypothermic Oxygenated Perfusion (HOPE) in pediatric liver transplantation—using any machine perfusion device— was presented ...

Bridge to Life™ Ltd., a global innovator in organ preservation and perfusion technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the ...

Bridge to Life™ Ltd., a global innovator in organ preservation and perfusion technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the ...